Uzbekistan to tighten Drug Controls

4 September 1994

Uzbekistan's president Islam Karmov has issued a decree on the sale of medicines which increases the penalties for violation of state norms and aims to improve medical supplies. Licenses will be issued by the Ministry of Health for the sale of medicines, and anyone selling them without a license will be investigated. The Interior Ministry will take "decisive measures" to prevent the sale of medicines in markets.

Heads of "pharmaceutical outlets" will be held personally responsible for the observance of procedures. The Ministries of Health and Finance and the state medicines body will ensure the listing of important and limited-supply drugs, which will be sold at fixed retail prices. Other drugs will have no price restrictions.

Local authorities are to "find the resources," including foreign currency, to buy medical supplies and distribute them. Central government is meanwhile drawing up measures to improve the supply and distribution of medicines.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight